IPSC stock icon

Century Therapeutics

1.26 USD
+0.11
9.57%
At close Nov 1, 4:00 PM EDT
After hours
1.32
+0.06
4.76%
1 day
9.57%
5 days
-9.35%
1 month
-23.64%
3 months
-39.71%
6 months
-58.55%
Year to date
-65.38%
1 year
-15.44%
5 years
-94.48%
 

About: Century Therapeutics Inc is a biotechnology company specializes in leveraging adult stem cells to develop advanced cell therapy products targeting cancer, autoimmune, and inflammatory diseases. Their innovative approach involves a genetically engineered allogeneic cell therapy platform comprising induced pluripotent stem cells (iPSCs), CRISPR-mediated precision gene editing, proprietary chimeric antigen receptors (CARs), Allo-EvasionTM technology, and cutting-edge manufacturing capabilities. This comprehensive platform aims to overcome the limitations of first-generation cell therapies by optimizing cell product performance, preventing rejection by the host immune system, and minimizing development and supply risks.

Employees: 165

0
Funds holding %
of 6,759 funds
Analysts bullish %

Fund manager confidence

Based on 2024 Q2 SEC filings by fund managers ($100M+ AUM)

1,700% more call options, than puts

Call options by funds: $18K | Put options by funds: $1K

129% more repeat investments, than reductions

Existing positions increased: 32 | Existing positions reduced: 14

11.44% more ownership

Funds ownership: 36.31% [Q1] → 47.75% (+11.44%) [Q2]

5% more capital invested

Capital invested by funds: $98.4M [Q1] → $103M (+$4.52M) [Q2]

8% less funds holding

Funds holding: 66 [Q1] → 61 (-5) [Q2]

42% less first-time investments, than exits

New positions opened: 7 | Existing positions closed: 12

Research analyst outlook

1 Wall Street Analyst provided 1 year price targets over the past 3 months

Low target
$9
614%
upside
Avg. target
$9
614%
upside
High target
$9
614%
upside

1 analyst rating

positive
100%
neutral
0%
negative
0%
HC Wainwright & Co.
Mitchell Kapoor
50% 1-year accuracy
66 / 131 met price target
614%upside
$9
Buy
Maintained
15 Aug 2024

Financial journalist opinion

Charts implemented using Lightweight Charts™